Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry Assay. Danziger N, Sokol ES, Graf RP, Hiemenz MC, et al. Oncologist 2023;28:319-326.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Danziger N, Sokol ES, Graf RP, Hiemenz MC, et al. Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry Assay. Oncologist 2023;28:319-326.
PMID: 36866462